相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Exogenous hydrogen sulfide (H2S) exerts therapeutic potential in triple-negative breast cancer by affecting cell cycle and DNA replication pathway
Xiaoyue Cui et al.
BIOMEDICINE & PHARMACOTHERAPY (2023)
Metformin and Cancer: Solutions to a Real-World Evidence Failure
Oriana Hoi Yun Yu et al.
DIABETES CARE (2023)
Erucin, an H2S-Releasing Isothiocyanate, Exerts Anticancer Effects in Human Triple-Negative Breast Cancer Cells Triggering Autophagy-Dependent Apoptotic Cell Death
Ivana Bello et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Hydrogen Sulfide (H2S): As a Potent Modulator and Therapeutic Prodrug in Cancer
Pawan Faris et al.
CURRENT MEDICINAL CHEMISTRY (2023)
Hydrogen sulfide: Recent development of its dual donors and hybrid drugs
Shi Xu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2023)
Prednisone-hydrogen sulfide releasing hybrid shows improved therapeutic profile in asthma
Ida Cerqua et al.
FRONTIERS IN PHARMACOLOGY (2023)
Hydrogen sulfide attenuates ferroptosis and stimulates autophagy by blocking mTOR signaling in sepsis-induced acute lung injury
Jianhua Li et al.
MOLECULAR IMMUNOLOGY (2022)
H2S donating corticosteroids: Design, synthesis and biological evaluation in a murine model of asthma
Angela Corvino et al.
JOURNAL OF ADVANCED RESEARCH (2022)
Design, Synthesis and Evaluation of Novel Molecular Hybrids between Antiglaucoma Drugs and H2S Donors
Rosa Sparaco et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Structure-activity relationships study of isothiocyanates for H2S releasing properties: 3-Pyridyl-isothiocyanate as a new promising cardioprotective agent
Valentina Citi et al.
JOURNAL OF ADVANCED RESEARCH (2021)
Cellular and Molecular Mechanisms of Metformin Action
Traci E. LaMoia et al.
ENDOCRINE REVIEWS (2021)
Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1
Tae Suk Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Role of hydrogen sulfide donors in cancer development and progression
Ebenezeri Erasto Ngowi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
Erucin exhibits vasorelaxing effects and antihypertensive activity by H2S-releasing properties
Alma Martelli et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Metformin and Vascular Diseases: A Focused Review on Smooth Muscle Cell Function
Mingying Deng et al.
FRONTIERS IN PHARMACOLOGY (2020)
Hydrogen sulfide and its donors: Novel antitumor and antimetastatic therapies for triple-negative breast cancer
Haonan Li et al.
REDOX BIOLOGY (2020)
Metformin induces cell cycle arrest, apoptosis and autophagy through ROS/JNK signaling pathway in human osteosarcoma
Bo Li et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
A new, vasoactive hybrid aspirin containing nitrogen monoxide-releasing molsidomine moiety
Kitti Szoke et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Isothiocyanates as H2S Donors Triggered by Cysteine: Reaction Mechanism and Structure and Activity Relationship
Yi Lin et al.
ORGANIC LETTERS (2019)
Design and synthesis of H2S-donor hybrids: A new treatment for Alzheimer's disease?
Simona Sestito et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Anticancer properties of erucin, an H2S-releasing isothiocyanate, on human pancreatic adenocarcinoma cells (AsPC-1)
Valentina Citi et al.
PHYTOTHERAPY RESEARCH (2019)
Metformin: Mechanisms in Human Obesity and Weight Loss
Armen Yerevanian et al.
CURRENT OBESITY REPORTS (2019)
Chemoprevention with isothiocyanates - From bench to bedside
Carsten Gruendemann et al.
CANCER LETTERS (2018)
Anti-Cancer Effects of Metformin: Recent Evidences for its Role in Prevention and Treatment of Cancer
Masoumeh Kheirandish et al.
CURRENT DRUG METABOLISM (2018)
Recent Developments in Drug Design of NO-donor Hybrid Compounds
Rajan Sharma et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2018)
Regulation of Organelle Function by Metformin
Jeongho Kim et al.
IUBMB LIFE (2017)
The impact of cruciferous vegetable isothiocyanates on histone acetylation and histone phosphorylation in bladder cancer
Besma Abbaoui et al.
JOURNAL OF PROTEOMICS (2017)
Metformin Inhibits Gemcitabine Induced Apoptosis in Pancreatic Cancer Cell Lines
Dietmar Zechner et al.
JOURNAL OF CANCER (2017)
Metformin: clinical use in type 2 diabetes
Elizabeth Sanchez-Rangel et al.
DIABETOLOGIA (2017)
Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC Inhibition
Stephanie M. Tortorella et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
Anti-Cancer Activity of New Designer Hydrogen Sulfide-Donating Hybrids
Khosrow Kashfi
ANTIOXIDANTS & REDOX SIGNALING (2014)
Metformin: From Mechanisms of Action to Therapies
Marc Foretz et al.
CELL METABOLISM (2014)
Fluorescent Probes Based on Nucleophilic Substitution-Cyclization for Hydrogen Sulfide Detection and Bioimaging
Bo Peng et al.
CHEMISTRY-A EUROPEAN JOURNAL (2014)
Hydrogen Sulfide Releasing Capacity of Natural Isothiocyanates: Is It a Reliable Explanation for the Multiple Biological Effects of Brassicaceae?
Valentina Citi et al.
PLANTA MEDICA (2014)
Cruciferous Vegetables: Dietary Phytochemicals for Cancer Prevention
Ahmad Faizal Abdull Razis et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras
Khosrow Kashfi et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: A general property and evidence of a tissue type-independent effect
Mitali Chattopadhyay et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Metformin and the Risk of Cancer Time-related biases in observational studies
Samy Suissa et al.
DIABETES CARE (2012)
Emerging role of hydrogen sulfide in health and disease: critical appraisal of biomarkers and pharmacological tools
Matthew Whiteman et al.
CLINICAL SCIENCE (2011)
COXIBs, CINODs and H2S-Releasing NSAIDs: Current Perspectives in the Development of Safer Non Steroidal Anti-Inflammatory Drugs
S. Fiorucci et al.
CURRENT MEDICINAL CHEMISTRY (2011)
The Slow-Releasing Hydrogen Sulfide Donor, GYY4137, Exhibits Novel Anti-Cancer Effects In Vitro and In Vivo
Zheng Wei Lee et al.
PLOS ONE (2011)
Hydrogen Sulfide-Releasing NSAIDs Attenuate Neuroinflammation Induced by Microglial and Astrocytic Activation
Moonhee Lee et al.
GLIA (2010)
Effects of Hydrogen Sulfide-releasing L-DOPA Derivatives on Glial Activation POTENTIAL FOR TREATING PARKINSON DISEASE
Moonhee Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Therapeutic potential of new hydrogen sulfide-releasing hybrids
Anna Sparatore et al.
Expert Review of Clinical Pharmacology (2010)
NO-glibenclamide derivatives: Prototypes of a new class of nitric oxide-releasing anti-diabetic drugs
Vincenzo Calderone et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro
Irina N. Alimova et al.
CELL CYCLE (2009)
A novel hybrid aspirin-NO-releasing compound inhibits TNFalpha release from LPS-activated human monocytes and macrophages
Catriona M. Turnbull et al.
JOURNAL OF INFLAMMATION-LONDON (2008)
NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs:: What lies beyond the horizon
S. Fiorucci et al.
DIGESTIVE AND LIVER DISEASE (2007)
Hydrogen sulfide mediates the vasoactivity of garlic
Gloria A. Benavides et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
NO-releasing hybrids of cardiovascular drugs
A Martelli et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
分享论文
